A new marijuana production facility attracted investors to a Canadian cannabis stock Wednesday. Here’s some small stocks making big moves on Wednesday, February 20, 2019 (as of 4 pm EST):
Emerald Health Therapeutics, Inc. (TSXV:EMH), a Canadian cannabis stock, jumped 16% to $3.92 on Wednesday after announcing the launch of Verdélite Sciences Inc., a wholly-owned, Québec-based production subsidiary licensed by Health Canada, which currently produces high-grade dried cannabis for medical and adult-use purposes.
As well, shares of Uni-Select Inc. (TSX:UNS) slid 23% to $14.90 as the provider of automotive refinish and industrial paint and related products said its fourth-quarter adjusted EBITDA fell 23% to $21.4 million.
OneSoft Solutions Inc. (TSXV:OSS), meanwhile, reported that its wholly-owned subsidiary has revealed that another software trial client has adopted OneBridge’s Cognitive Integrity Management software-as-a-service solution for long-term use. OneSoft Solutions stock moved up 20% to $0.72 following the announcement.
Finally, Barkerville Gold Mines Ltd. (TSXV:BGM) shares rose 6% to $0.455 after the gold explorer announced final drilling results from the 2018 Island Mountain exploration and category conversion program at its Cariboo Gold Project in British Columbia, which included 7.75 g/t gold over 46.0 meters.
Disclosure: Neither the author nor his family own shares in any of the companies mentioned above.
To read our full disclosure, please click on the button below:
The Content contained on this page (including any facts, views, opinions, recommendations, description of, or references to, products or securities) made available by SmallCapPower/Ubika Research is for information purposes only and is not tailored to the needs or circumstances of any particular person. Any mention of a particular security is merely a general discussion of the merits and risks associated there with and is not to be used or construed as an offer to sell, a solicitation of an offer to buy, or an endorsement, recommendation, or sponsorship of any entity or security by SmallCapPower/Ubika Research. The Reader should apply his/her own judgment in making any use of any Content, including, without limitation, the use of any information contained therein as the basis for any conclusions. The Reader bears responsibility for his/her own investment research and decisions. Before making any investment decision, it is strongly recommended that you seek outside advice from a qualified investment advisor. SmallCapPower/Ubika Research does not provide or guarantee any financial, legal, tax, or accounting advice or advice regarding the suitability, profitability, or potential value of any particular investment, security, or information source. Ubika and/or its affiliates and/or their respective officers, directors or employees may from time to time acquire, hold or sell securities and/or commodities and/or commodity futures contracts in certain underlying companies mentioned in this site and which may also be clients of Ubika’s affiliates. In such instances, Ubika and/or its affiliates and/or their respective officers, directors or employees will use all reasonable efforts to avoid engaging in activities that would lead to conflicts of interest and Ubika and/or its affiliates will use all reasonable efforts to comply with conflicts of interest disclosures and regulations to minimize the conflict.
Emerald Health Therapeutics, Inc. (TSXV:EMH), a Canadian cannabis stock, jumped 16% to $3.92 on Wednesday after announcing the launch of Verdélite Sciences Inc., a wholly-owned, Québec-based production subsidiary licensed by Health Canada, which currently produces high-grade dried cannabis for medical and adult-use purposes.
